ABOUT US
|
|
Our Mission |
|
The mission of Innovative Biosystems Inc. is to meet the health care needs of the world by providing convenient and cost effective Point of care testing for early diagnosis, treatment and monitoring of patients. Infectious disease, heart disease and diabetes represent the major cause for the health care costs in most developed countries where there is a growing aging population. In addition, there are delays in diagnosis and treatment of patients in many parts of Asia, Africa, and South America. IBI point –of-care products will provide needed, meaningful and accurate information about patient blood testing results both quickly and economically. |
|
|
|
|
|
|
|
|
|
Our Opportunity |
|
The goal of the company is to gain a market share in the approximately $1 billion Veterinary blood testing and $15 billion Medical blood testing market worldwide with a point-of-care (POC) analyzer (MAX-90) and other related POC testing products. PT/INR blood coagulation testing alone represents $750 million of this market and is expected to grow significantly over the next 10 years. |
|
|
|
|
|
|
|